NTRK1 and breast carcinoma: ErbB2/HER2 (human epidermal growth factor receptor 2) is an oncogenic tyrosine kinase receptor overexpressed in 25% of primary human breast cancer cases as a result of ErbB2 gene amplification or enhanced expression.